A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer
Overview
The purpose of this trial is to study the efficacy of preoperative radiation therapy and capecitabine in locally advanced rectal cancer.
Full Title of Study: “A Phase 2 Study of Preoperative Radiation Therapy and Capecitabine (an Oral Fluoropyrimidine Carbamate) in Locally Advanced Rectal Cancer”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Non-Randomized
- Intervention Model: Single Group Assignment
- Primary Purpose: Treatment
- Masking: None (Open Label)
Detailed Description
The purpose of this trial is to study the efficacy of preoperative radiation therapy and capecitabine in locally advanced rectal cancer.
Interventions
- Drug: Capecitabine
- Procedure: Pelvic radiation
Clinical Trial Outcome Measures
Primary Measures
- safety
- response
Participating in This Clinical Trial
Inclusion Criteria
- Biopsy – proven rectal cancer – Transmural rectal wall invasion – Karnofsky performance status >70 – Normal bone marrow, liver and kidney function Exclusion Criteria:
- Distant metastases – Prior pelvic radiation – Inflammatory bowel disease – Severe ischemic heart disease – Anticoagulant therapy – Pregnancy
Gender Eligibility: All
Minimum Age: 17 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Alberta Health services
- Overall Official(s)
- Gwyn Bebb, MD, Principal Investigator, Alberta Health services
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.